Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network.
Autorzy:
Warren-Gash C; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Cadogan SL; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Nicholas JM; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom. Breuer JM; Institute of Child Health, University College London, Gower Street, London, WC1E 6BT, United Kingdom.; Virology Department, Great Ormond Street Hospital, London, United Kingdom. Shah D; Virology Department, Great Ormond Street Hospital, London, United Kingdom. Pearce N; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom. Shiekh S; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Smeeth L; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Farlow MR; Indiana University School of Medicine, Indianapolis, Indiana, USA. Mori H; Department of Clinical Neuroscience, Osaka Metropolitan University Medical School, Sutoku University, Osaka, Japan. Gordon BA; Department of Radiology, Washington University School of Medicine in St Louis, Missouri, USA. Nuebling G; German Center for Neurodegenerative Diseases, Site Munich, Germany.; Department of Neurology, Ludwig-Maximilians University, Munich, Germany. McDade E; Department of Neurology, Washington University School of Medicine, St. Louis, USA. Bateman RJ; Department of Neurology, Washington University School of Medicine, St. Louis, USA. Schofield PR; Neuroscience Research Australia, Sydney, New South Wales, Australia.; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia. Lee JH; Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Morris JC; Department of Neurology, Washington University School of Medicine, St. Louis, USA. Cash DM; UK Dementia Research Institute, University College London, London, United Kingdom.; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom. Fox NC; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom. RidhaBH; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom. Rossor MN; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Autorzy:
Femminella GD; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Livingston NR; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Raza S; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. van der Doef T; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Frangou E; University of Oxford, Oxford, UK. Love S; University of Oxford, Oxford, UK. Busza G; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Calsolaro V; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Carver S; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Holmes C; University of Southampton, Southampton, UK. Ritchie CW; University of Edinburgh, Edinburgh, UK. Lawrence RM; South West London and St George's Mental Health NHS Trust, London, UK. McFarlane B; Southern Health NHS Foundation Trust, Southampton, UK. Tadros G; Heart of England NHS Foundation Trust, Birmingham, UK. RidhaBH; Brighton and Sussex University Hospital Trust, Brighton, UK. Bannister C; King's College London, London, UK. Walker Z; Mental Health Unit, St. Margaret's Hospital, Epping, Essex, UK. Archer H; North Bristol NHS Trust, Bristol, UK. Coulthard E; North Bristol NHS Trust, Bristol, UK. Underwood B; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK. Prasanna A; Black Country Partnership NHS Foundation Trust, Wolverhampton, UK. Koranteng P; Northamptonshire Healthcare NHS Foundation Trust, Northampton, UK. Karim S; Lancashire Care NHS Foundation Trust, Preston, UK. Junaid K; Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK. McGuinness B; Queen's University Belfast, Belfast, UK. Passmore AP; Queen's University Belfast, Belfast, UK. Nilforooshan R; Surrey and Borders Partnership NHS Foundation Trust, Chertsey, UK. Macharouthu A; NHS Ayrshire and Arran, Kilmarnock, UK. Donaldson A; NHS Lanarkshire, Airdrie, UK. Thacker S; Derbyshire Healthcare NHS Foundation Trust, Derby, UK. Russell G; Bradford District Care NHS Foundation Trust, Bradford, UK. Malik N; North West Boroughs Partnership NHS Foundation Trust, Warrington, UK. Mate V; Cornwall Partnership NHS Foundation Trust, Redruth, UK. Knight L; Somerset Partnership NHS Foundation Trust, South Petherton, UK. Kshemendran S; South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Shrewsbury, UK. Tan T; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Holscher C; Research and Experimental Center, Henan University of Chinese Medicine, Zhengzhou, China. Harrison J; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. Brooks DJ; Newcastle University, Newcastle upon Tyne, UK. Ballard C; University of Exeter Medical School, Exeter, UK. Edison P; Division of Neurology, Neurology Imaging Unit, Department of Brain Sciences, Imperial College London, 1st Floor B Block, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Feb 17; Vol. 13 (1), pp. 47. Date of Electronic Publication: 2021 Feb 17.
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Autorzy:
Femminella GD; Department of Medicine, Imperial College London, London, UK. Frangou E; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Love SB; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Busza G; Department of Medicine, Imperial College London, London, UK. Holmes C; Southern Health NHS Foundation Trust, Havant, UK. Ritchie C; Department of Medicine, Imperial College London, London, UK. Lawrence R; SW London and St George's Mental Health Trust, London, UK. McFarlane B; Southern Health NHS Foundation Trust, Havant, UK. Tadros G; Aston Medical school, Aston University, Birmingham, UK. RidhaBH; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. Bannister C; South London and Maudsley NHS Foundation Trust, London, UK. Walker Z; University College London and Essex Partnership University NHS Foundation Trust, Runwell, UK. Archer H; North Bristol NHS Trust, Bristol, UK. Coulthard E; North Bristol NHS Trust, Bristol, UK. Underwood BR; Cambridgeshire and Peterborough NHS Foundation Trust, Peterborough, UK. Prasanna A; Black Country Partnership NHS Foundation Trust, West Bromwich, UK. Koranteng P; Northamptonshire Healthcare NHS Foundation Trust, Kettering, UK. Karim S; Lancashire Care NHS Foundation Trust, Preston, UK. Junaid K; Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK. McGuinness B; Centre for Public Health, Queen's University Belfast, Belfast, UK. Nilforooshan R; Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK. Macharouthu A; NHS Ayrshire and Arran, Crosshouse, UK. Donaldson A; NHS Lanarkshire, Glasgow, UK. Thacker S; Derbyshire Healthcare NHS Foundation Trust, Derby, UK. Russell G; Bradford District Care NHS Foundation Trust, Bradford, UK. Malik N; 5 Boroughs Partnership NHS Foundation Trust, Warrington, UK. Mate V; Cornwall Partnership NHS Foundation Trust, Redruth, UK. Knight L; Somerset Partnership NHS Foundation Trust, Bridgwater, UK. Kshemendran S; South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Stafford, UK. Harrison J; Alzheimer Center VUmc Amsterdam, Amsterdam, the Netherlands.; Institute of Psychiatry, Psychology & Neuroscience King's College London, London, UK. Hölscher C; Research Department, Henan University of Chinese Medicine, Zhengzhou, China. Brooks DJ; Department of Medicine, Imperial College London, London, UK.; Newcastle University, Newcastle upon Tyne, UK. Passmore AP; Centre for Public Health, Queen's University Belfast, Belfast, UK. Ballard C; South London and Maudsley NHS Foundation Trust, London, UK. Edison P; Department of Medicine, Imperial College London, London, UK. .; School of Medicine, College of Biomedical and Life sciences, Cardiff University, Cardiff, CF14 4YS, UK. .
Pokaż więcej
Źródło:
Trials [Trials] 2020 Jul 19; Vol. 21 (1), pp. 660. Date of Electronic Publication: 2020 Jul 19.
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Autorzy:
Femminella GD; Department of Medicine, Imperial College London, London, UK. Frangou E; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Love SB; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Busza G; Department of Medicine, Imperial College London, London, UK. Holmes C; Southern Health NHS Foundation Trust, Havant, UK. Ritchie C; Department of Medicine, Imperial College London, London, UK. Lawrence R; SW London and St George's Mental Health Trust, London , UK. McFarlane B; Southern Health NHS Foundation Trust, Havant, UK. Tadros G; Aston Medical school, Aston University, Birmingham, UK. RidhaBH; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. Bannister C; South London and Maudsley NHS Foundation Trust, London, UK. Walker Z; University College London and Essex Partnership University NHS Foundation Trust, Runwell, UK. Archer H; North Bristol NHS Trust, Bristol, UK. Coulthard E; North Bristol NHS Trust, Bristol, UK. Underwood BR; Cambridgeshire and Peterborough NHS Foundation Trust, Peterborough, UK. Prasanna A; Black Country Partnership NHS Foundation Trust, West Bromwich, UK. Koranteng P; Northamptonshire Healthcare NHS Foundation Trust, Kettering, UK. Karim S; Lancashire Care NHS Foundation Trust, Preston, UK. Junaid K; Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK. McGuinness B; Centre for Public Health, Queen's University Belfast, Belfast, UK. Nilforooshan R; Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK. Macharouthu A; NHS Ayrshire and Arran, Crosshouse, UK. Donaldson A; NHS Lanarkshire, Glasgow, UK. Thacker S; Derbyshire Healthcare NHS Foundation Trust, Derby, UK. Russell G; Bradford District Care NHS Foundation Trust, Bradford, UK. Malik N; 5 Boroughs Partnership NHS Foundation Trust, Warrington, UK. Mate V; Cornwall Partnership NHS Foundation Trust, Redruth, UK. Knight L; Somerset Partnership NHS Foundation Trust, Bridgwater, UK. Kshemendran S; South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Stafford, UK. Harrison J; Alzheimer Center VUmc Amsterdam, Amsterdam, the Netherlands.; Institute of Psychiatry, Psychology & Neuroscience King's College London, London, UK. Hölscher C Brooks DJ; Department of Medicine, Imperial College London, London, UK.; Newcastle University, Newcastle upon Tyne, UK. Passmore AP; Centre for Public Health, Queen's University Belfast, Belfast, UK. Ballard C; South London and Maudsley NHS Foundation Trust, London, UK. Edison P; Department of Medicine, Imperial College London, London, UK. .; School of Medicine, College of Biomedical and Life sciences, Cardiff University, Cardiff, CF14 4YS, UK. .
Pokaż więcej
Źródło:
Trials [Trials] 2019 Apr 03; Vol. 20 (1), pp. 191. Date of Electronic Publication: 2019 Apr 03.
Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia.
Autorzy:
Woollacott IOC; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK. Bocchetta M; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK. Sudre CH; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK.; b Translational Imaging Group, Centre for Medical Image Computing , University College London , London , UK. RidhaBH; c NIHR Queen Square Dementia Biomedical Research Unit , UCL Institute of Neurology , London , UK. Strand C; d Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience , UCL Institute of Neurology , London , UK. Courtney R; d Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience , UCL Institute of Neurology , London , UK. Ourselin S; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK.; b Translational Imaging Group, Centre for Medical Image Computing , University College London , London , UK. Cardoso MJ; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK.; b Translational Imaging Group, Centre for Medical Image Computing , University College London , London , UK. Warren JD; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK. Rossor MN; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK. Revesz T; d Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience , UCL Institute of Neurology , London , UK. Fox NC; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK. Holton JL; d Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience , UCL Institute of Neurology , London , UK. Lashley T; d Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience , UCL Institute of Neurology , London , UK. Rohrer JD; a Dementia Research Centre, Department of Neurodegenerative Disease , UCL Institute of Neurology , London , UK.
Pokaż więcej
Źródło:
Neurocase [Neurocase] 2018 Jun; Vol. 24 (3), pp. 166-174. Date of Electronic Publication: 2018 Aug 16.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.
Autorzy:
RidhaBH; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Crutch S; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Cutler D; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Frost C; London School of Hygiene and Tropical Medicine, University of London, London, UK. Knight W; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Barker S; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Epie N; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Warrington EK; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Kukkastenvehmas R; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Douglas J; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. Rossor MN; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2018 May 01; Vol. 10 (1), pp. 44. Date of Electronic Publication: 2018 May 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Clinical use of brain magnetic resonance imaging for neurological symptoms in people living with HIV.
Autorzy:
Kent L; Brighton and Sussex Medical School, University of Sussex, Brighton, UK. Amlani A; Brighton and Sussex University Hospital NHS Trust, Brighton, UK. Vundavalli S; Brighton and Sussex University Hospital NHS Trust, Brighton, UK. RidhaBH; Brighton and Sussex University Hospital NHS Trust, Brighton, UK. Vera JH; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; Brighton and Sussex University Hospital NHS Trust, Brighton, UK.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2018 Jan 19. Date of Electronic Publication: 2018 Jan 19.
Donepezil enhances understanding of degraded speech in Alzheimer's disease.
Autorzy:
Hardy CJD; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. Hwang YT; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. Bond RL; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. Marshall CR; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. RidhaBH; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. Crutch SJ; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. Rossor MN; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom. Warren JD; Dementia Research Centre Department of Neurodegenerative Disease Institute of Neurology University College London London United Kingdom.
Homonymous Sectoranopia: Asymptomatic Presentation of a Lateral Geniculate Nucleus Lesion.
Autorzy:
Pasu S; Medical Eye Unit, St. Thomas' Hospital , London, UK. RidhaBH; Medical Eye Unit, St. Thomas' Hospital, London, UK, ; Institute of Neurology, University College London, London, UK. Wagh V; Medical Eye Unit, St. Thomas' Hospital , London, UK. Jindahra P; Division of Neurology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University , Bangkok, Thailand , and. Siddiqui A; Department of Radiology, St. Thomas' Hospital , London, UK. Plant G; Medical Eye Unit, St. Thomas' Hospital, London, UK, ; Institute of Neurology, University College London, London, UK. Stanford M; Medical Eye Unit, St. Thomas' Hospital , London, UK.
Pokaż więcej
Źródło:
Neuro-ophthalmology (Aeolus Press) [Neuroophthalmology] 2015 Nov 11; Vol. 39 (6), pp. 289-294. Date of Electronic Publication: 2015 Nov 11 (Print Publication: 2015).
Ocular Flutter Following Adenoviral Conjunctivitis in an Adult.
Autorzy:
Sira MS; Department of Neuro-Ophthalmology, Moorfields Eye Hospital, London, United Kingdom. RidhaBH; Department of Neurology, St. Thomas' Hospital, London, United Kingdom. Petzold A; Department of Neuroimmunology, Institute of Neurology, Queen Square, London, United Kingdom. Plant GT; Department of Neuro-Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
Pokaż więcej
Źródło:
Neuro-ophthalmology (Aeolus Press) [Neuroophthalmology] 2010 Oct 06; Vol. 35 (1), pp. 22-23. Date of Electronic Publication: 2010 Oct 06 (Print Publication: 2011).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
